Tumor suppressive activity of anti-CD274 antibody as an immune checkpoint inhibitor for cervical cancer mouse model

被引：0

作者：

Murakami, Kazuyuki ^{[1
]}

Yoshino, Naoto ^{[2
]}

Kawamura, Hanae ^{[1
]}

Sasaki, Yutaka ^{[2
]}

Kagabu, Masahiro ^{[1
]}

Muraki, Yasushi ^{[2
]}

Sugiyama, Toru ^{[1
]}

机构：

[1] Iwate Med Univ, Sch Med, Dept Obstet & Gynecol, Morioka, Iwate, Japan

[2] Iwate Med Univ, Sch Med, Div Infect Dis & Immunol, Dept Microbiol, Morioka, Iwate, Japan

来源：

JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 2015年 / 112卷

关键词：

D O I：

10.1016/j.jri.2015.09.059

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：139 / 139

页数：1

共 50 条

[21] The HDAC inhibitor belinostat enhances the anti-tumor efficacy of immune checkpoint inhibitors in a murine hepatocellular carcinoma model
Llopiz, D.
Ruiz, M.
Villanueva, L.
Iglesias, T.
Lasarte, J. J.
Pivette, P.
Trocon-Joseph, V.
Vasseur, B.
Dixon, G.
Sangro, B.
Sarobe, P.
JOURNAL OF HEPATOLOGY, 2018, 68 : S677 - S677
[22] COMBINATION THERAPY WITH A HYPOMETHYLATING DRUG (DECITABINE) PLUS AN IMMUNE CHECKPOINT INHIBITOR (ANTI-PD-1H) IN THE KPC MOUSE MODEL OF PANCREATIC CANCER
Gonda, Tamas A.
Tycko, Benjamin
Salas, Martha C.
Do, Catherine
Fang, Jarwei
Olive, Kenneth P.
GASTROENTEROLOGY, 2017, 152 (05) : S42 - S43
[23] Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor
Deng, Rong
Bumbaca, Daniela
Pastuskovas, Cinthia V.
Boswell, C. Andrew
West, David
Cowan, Kyra J.
Chiu, Henry
McBride, Jacqueline
Johnson, Clarissa
Xin, Yan
Koeppen, Hartmut
Leabman, Maya
Iyer, Suhasini
MABS, 2016, 8 (03) : 593 - 603
[24] Cowpea Mosaic Virus Promotes Anti-Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model
Wang, Chao
Fiering, Steven N.
Steinmetz, Nicole F.
ADVANCED THERAPEUTICS, 2019, 2 (05)
[25] Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy
Denis, Morgane
Mathe, Doriane
Micoud, Manon
Choffour, Pierre-Antoine
Grasselly, Chloe
Matera, Eva-Laure
Dumontet, Charles
FRONTIERS IN IMMUNOLOGY, 2023, 13
[26] Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
Yorita, Naoki
Yuge, Ryo
Takigawa, Hidehiko
Ono, Atsushi
Kuwai, Toshio
Kuraoka, Kazuya
Kitadai, Yasuhiko
Tanaka, Shinji
Chayama, Kazuaki
CANCER LETTERS, 2021, 498 : 111 - 120
[27] Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy
Vahle, Anne-Kristin
Hermann, Sven
Schaefers, Michael
Wildner, Michael
Kerem, Alexander
Oeztuerk, Ender
Jure-Kunkel, Maria
Franklin, Cindy
Lang, Stephan
Brandau, Sven
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (04): : 542 - 549
[28] A Novel CD73 Inhibitor SHRI70008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-I Blockade in a Mouse Model of Breast Cancer
Liu, Suxing
Li, Di
Liu, Jian
Wang, Huiyun
Horecny, Ivana
Shen, Ru
Zhang, Rumin
Wu, Heping
Hu, Qiyue
Zhao, Peng
Zhang, Fengqi
Yan, Yinfa
Feng, Jun
Zhuang, Linghang
Li, Jing
Zhang, Lianshan
Tao, Weikang
ONCOTARGETS AND THERAPY, 2021, 14 : 4561 - 4574
[29] Intravesical Anti-PD-1 Immune Checkpoint Inhibition Treats Urothelial Bladder Cancer in a Mouse Model
Kirschner, Austin N.
Wang, Jian
Rajkumar-Calkins, Anne
Neuzil, Kevin E.
Chang, Sam S.
JOURNAL OF UROLOGY, 2021, 205 (05): : 1336 - 1343
[30] Tumor treating fields (TTFields) induce an anti-tumor immune response in a pancreatic cancer mouse model
Kan, Tal
Khalil, Tharwat Haj
Barsheshet, Yiftah
Voloshin, Tali
Vorontsov, Avital
Brant, Boris
Koren, Lilach
Blatt, Roni
Cahal, Shay
Zemer-Tov, Efrat
Paz, Rom
Klein-Goldberg, Anat
Brami, Catherine Tempel
Jacobovitch, Sara
Volodin, Alexandra
Koltun, Bella
David, Cfir
Haber, Adi
Giladi, Moshe
Weinberg, Uri
Palti, Yoram
CANCER RESEARCH, 2024, 84 (06)

← 1 2 3 4 5 →